(Total Views: 467)
Posted On: 11/28/2018 1:09:44 PM
Post# of 30034
- Ciron will develop and manufacture several drugs exclusively for Coeptis to market in the U.S. under its label. According to IMS Health, the drugs have a total U.S. sales of more than $100 million.
https://www.biospace.com/article/coeptis-pharma-to-buy-elto-pharma/
"independent third-party valuation report which valued the Parkinson's disease levodopa-induced dyskinesia (PD-LID) indication for Eltoprazine in the US and Europe at $316 million."
https://www.amarantus.com/news/press-releases...-formation
100 mil + 316 mil = Uplist
Aloha
https://www.biospace.com/article/coeptis-pharma-to-buy-elto-pharma/
"independent third-party valuation report which valued the Parkinson's disease levodopa-induced dyskinesia (PD-LID) indication for Eltoprazine in the US and Europe at $316 million."
https://www.amarantus.com/news/press-releases...-formation
100 mil + 316 mil = Uplist
Aloha
(2)
(0)Scroll down for more posts ▼
